RUNX1 and lymphoma: Some scholars have found that combined transgenic mice, with T cells or B cells overexpressing MYC and RUNX1 genes, are easily accessible to lymphoma, suggesting that RUNX1 can accelerate MYC-induced lymphoma [43].